Literature DB >> 16971981

Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Jarmila Machackova1, Judit Barta, Naranjan S Dhalla.   

Abstract

BACKGROUND: A wide variety of pathological conditions have been shown to result in cardiac remodelling and myocardial dysfunction. However, the mechanisms of transition from adaptive to maladaptive alterations, as well as those for changes in cardiac performance leading to heart failure, are poorly understood. OBSERVATIONS: Extensive studies have revealed a broad spectrum of progressive changes in subcellular structures and function, as well as in signal transduction and metabolism in the heart, among different cardiovascular disorders. The present review is focused on identifying the alterations in molecular and biochemical structure of myofibrils (myofibrillar remodelling) in hypertrophied and failing myocardium in different types of heart diseases. Numerous changes at the level of gene expression for both contractile and regulatory proteins have already been reported in failing hearts and heart diseases; these changes are potential precursors for heart failure such as cardiac hypertrophy and cardiomyopathies. Myofibrillar remodelling, as a consequence of proteolysis, oxidation, and phosphorylation of some functional groups in both contractile and regulatory proteins in hearts failing due to different etiologies, has also been described.
CONCLUSIONS: Although myofibrillar remodelling appears to be associated with cardiac dysfunction, alterations in both contractile and regulatory proteins are dependent on the type and stage of heart disease.

Entities:  

Mesh:

Year:  2006        PMID: 16971981      PMCID: PMC2570240          DOI: 10.1016/s0828-282x(06)70315-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  242 in total

1.  Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments.

Authors:  Nicolaas de Jonge; Dick F van Wichen; Marguerite E I Schipper; Jaap R Lahpor; Frits H J Gmelig-Meyling; Etienne O Robles de Medina; Roel A de Weger
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

2.  Mass spectral determination of skeletal/cardiac actin isoform ratios in cardiac muscle.

Authors:  H Robert Bergen; Katalin Ajtai; Thomas P Burghardt; Angelito I Nepomuceno; David C Muddiman
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

3.  Myofibrillar adenosine triphosphatase activity in congestive heart failure.

Authors:  N R ALPERT; M S GORDON
Journal:  Am J Physiol       Date:  1962-05

4.  Effect of protein kinase A on calcium sensitivity of force and its sarcomere length dependence in human cardiomyocytes.

Authors:  J van der Velden; J W de Jong; V J Owen; P B Burton; G J Stienen
Journal:  Cardiovasc Res       Date:  2000-06       Impact factor: 10.787

5.  Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat.

Authors:  X Gu; S P Bishop
Journal:  Circ Res       Date:  1994-11       Impact factor: 17.367

6.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.

Authors:  J David Barrans; Paul D Allen; Dimitrios Stamatiou; Victor J Dzau; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

7.  Myosin light chain gene expression associated with disease states of the human heart.

Authors:  T Trahair; T Yeoh; T Cartmill; A Keogh; P Spratt; V Chang; C G dos Remedios; P Gunning
Journal:  J Mol Cell Cardiol       Date:  1993-05       Impact factor: 5.000

8.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

9.  Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts.

Authors:  J L Garvey; E G Kranias; R J Solaro
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

10.  Alpha-skeletal actin is associated with increased contractility in the mouse heart.

Authors:  T E Hewett; I L Grupp; G Grupp; J Robbins
Journal:  Circ Res       Date:  1994-04       Impact factor: 17.367

View more
  29 in total

1.  Matrix elasticity regulates the optimal cardiac myocyte shape for contractility.

Authors:  Megan L McCain; Hongyan Yuan; Francesco S Pasqualini; Patrick H Campbell; Kevin Kit Parker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-28       Impact factor: 4.733

Review 2.  βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Authors:  Julio Cesar Batista Ferreira; Patricia Chakur Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

Review 3.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  C57BL/6 neuromuscular healthspan scoring system.

Authors:  Ted G Graber; Lisa Ferguson-Stegall; Jong-Hee Kim; LaDora V Thompson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-04-12       Impact factor: 6.053

5.  Temporal alterations in cardiac fibroblast function following induction of pressure overload.

Authors:  James A Stewart; Erin P Massey; Charity Fix; Jinyu Zhu; Edie C Goldsmith; Wayne Carver
Journal:  Cell Tissue Res       Date:  2010-03-09       Impact factor: 5.249

6.  Novel large-particle FACS purification of adult ventricular myocytes reveals accumulation of myosin and actin disproportionate to cell size and proteome in normal post-weaning development.

Authors:  Javier E López; Janhavi Sharma; Jorge Avila; Taylor S Wood; Jonathan E VanDyke; Bridget McLaughlin; Craig K Abbey; Andrew Wong; Bat-Erdene Myagmar; Philip M Swigart; Paul C Simpson; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2017-08-02       Impact factor: 5.000

7.  Role of neuropeptide Y and peroxisome proliferator-activated receptor γ coactivator-1α in stress cardiomyopathy.

Authors:  Sunnassee Ananda; Yunyun Wang; Shaohua Zhu; Rongshuai Wang; Xiaowei Zhou; Luo Zhuo; Tingyi Sun; Liang Ren; Qian Liu; Hongmei Dong; Yan Liu; Liang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

Review 8.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease.

Authors:  David Barefield; Sakthivel Sadayappan
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

9.  Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors.

Authors:  Keshore R Bidasee; Hong Zheng; Chun-Hong Shao; Sheeva K Parbhu; George J Rozanski; Kaushik P Patel
Journal:  J Appl Physiol (1985)       Date:  2008-06-26

10.  Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling.

Authors:  Di-Fei Shen; Qi-Zhu Tang; Ling Yan; Yan Zhang; Li-Hua Zhu; Lang Wang; Chen Liu; Zhou-Yan Bian; Hongliang Li
Journal:  Br J Pharmacol       Date:  2010-01-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.